Key HighlightsSelectQuote (NYSE:SLQT) appears on the aggressive small cap screen with a one-year EPS change of 159.38% and aMarket Valueof about USD 81 million, at USD 0.45 in the November 13 snapshot, down 7.53% on the session.Fiscal first quarterRevenuefell 14.8% to USD 280.0 million, …
The Rationale: Last Reported Quarter and Management Outlook for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
First half 2026 net income was USD 10.9 million, or USD 6.72 per basic share, compared with USD 12.4 million, or USD 7.37, a year earlier. Second quarter oilRevenuewas USD 40.6 million at a realized price of USD 98.85 per barrel, against USD 56.96 …
Key HighlightsAlphabet's depositary share (NASDAQ:GOOGM) appears on the aggressive small cap screen at USD 42.78 in the November 13 snapshot, with a 52-week range of USD 40.97 to USD 53.13 and aMarket Valueshown as zero.Each GOOGM share represents a 1/20th interest in a share …
Key Highlights10.7 million USD was theRevenueIdaho Strategic Resources, Inc. (NYSEAMERICAN:IDR) reported for the second quarter of 2026, up 13.25% from USD 9.5 million, driven by a realized gold price of USD 4,277.53 per ounce.3.65 million USD was the second quarterNet Incomeattributable to the company, …
Key HighlightsTaboola.com (NASDAQ:TBLA) appears on the aggressive small cap screen with a one-year EPS change of 469.09%, a trailing P/E of 4.56 and aMarket Valueof about USD 571 million, at USD 2.16 in the November 13 snapshot.Third quarterRevenuefell 6.9% to USD 462.3 million, but …
Second quarter operating expenses were USD 35.7 million, up from USD 12.5 million, while the net loss from continuing operations narrowed to USD 34.0 million from USD 75.1 million, mainly becauseFair Valueadjustments on convertible notes were lower. Revenue growth came from acquisitions, including Renergen, …
Key HighlightsFTAI Infrastructure (NASDAQ:FIP) appears on the aggressive small cap screen with a one-year EPS change of 116.71% and aMarket Valueof about USD 481 million, at USD 4.07 in the November 13 snapshot.Third quarterRevenuerose about 56% to USD 219.0 million, and adjusted EBITDA reached …
The Rationale: Last Reported Quarter and Management Outlook for Fulcrum Therapeutics, Inc. (NASDAQ:FULC)
Key HighlightsCytek Biosciences (NASDAQ:CTKB) appears on the aggressive small cap screen with a one-year EPS change of 506.68% and aMarket Valueof about USD 732 million, at USD 5.62 in the November 13 snapshot, near its 52-week high of USD 6.34.Third quarterRevenuerose 2% to USD …